Does Helicobacter Pylori Co-Infection Contribute to Hepatitis C VirusAssociated Thrombocytopenia in Egyptian Patients?
Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 10
Abstract
Background: Despite the strong association between HCV and H. pylori co infection and the well-known relation between H. pylori and immune thrombocytopenia, there is no available literature concerning the relation between HCV-associated thrombocytopenia and H. pylori. Objectives: The aim of the present study was to investigate the frequency of H. pylorico infection in Egyptian patients with chronic HCV infection with and without thrombocytopenia and whether anti-H.pylori therapy would improve thrombocytopenia in those patients. Methods: 160 patients with chronic HCV infection including 80 patients with thrombocytopenia and 80 patients with normal platelet counts were enrolled in the study. Patients with hypersplenism, advanced liver disease or receiving antiviral therapy were excluded. H. pylori antigen was detected in the stools by rapid test. Triple therapy was administered to 30 H. pylori-positive thrombocytopenic patients for two weeks. Results: H. pylori was detected in 123 out of 160 (76.90%) HCV patients. Moreover, a significantly greater number of thrombocytopenic patients (67/80) had positive stool test for H.pylori compared to HCV patients with normal platelet counts (56/80);{p=0.039}. 19 out of 30 patients responded significantly to antihelicobacter therapy with increase or normalization of platelet counts (p=0.001).H.pylori was eradicated in all of those 19 subjects. Conclusion: To our knowledge, this is the first study to suggest a strong association between HCV-associated thrombocytopenia and H. pylori. The significant platelet response to eradication of the bacterium may open the door for anti-Helicobacter therapy as an adjuvant in the management of this difficult disease. Therefore, screening for H. pylori infection and an attempt to eradicate the bacterium in positive cases seems appropriate in all patients with HCV-associated thrombocytopenia at diagnosis. Randomized placebo-controlled clinical trials are warranted.
Authors and Affiliations
Nadia E Zaki
Keywords
Related Articles
- EP ID EP209590
- DOI -
- Views 62
- Downloads 0
Clinical and Metabolic changes after the Non- surgical Periodontal Therapy in patients with Type-2 Diabetes Mellitus with Chronic periodontitis with or without the Systemic administration of Azithromycin - A Randomized Controlled Clinical Trial
Background & Objectives: There is growing evidence that periodontitis may affect general health. Periodontal disease is now recognized as the sixth complication of diabetes. It has been suggested that an alteration in gl...
Histopathological Study of Endometrium in Dysfunctional Uterine Bleeding
Abstract
Estimation of Serum Lipids in Colorectal Carcinoma: A Prospective Study
To investigate the correlation between lipid metabolism disorder and the occurrence and development of colorectal cancer by monitoring the alteration in lipid levels in cancerous tissue and serum in patient with colo rec...
Ileal Adenocarcinoma – A Case Report
Small bowel malignancies are a rare clinical entity and accounts for only 1-3% of GI malignancies. Adenocarcinoma is the most common histopathological variety but its frequency decreases at distal locations. Most of smal...
Role of Saccharomyces Boulardii and Bacillus Clausii in Children with Acute Diarrhea – A Randomized Control Trial
Background: Probiotics are live microorganisms which when administered confer benefits to host. They are recommended as add on therapy for acute diarrhea. Objectives: To find out the effect of probiotics, Saccharomyces b...